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The eukaryotic genome is packaged into a highly ordered chromatin structure, with specific
domains regulating the transcription patterns of local genes. Hathaway et al. now present a
breakthrough technique in the artificial induction of chromatin marks and use this experimental
model to test the properties of an induced heterochromatic domain.The packaging of eukaryotic genomes
into chromatin is not uniform, as different
parts of the genome are packaged into
more or less accessible domains that in
turn affect the transcription of genes
embedded in these domains. The field of
chromatin structure and function has
been revolutionized in the past decade
by the advent of genome-wide studies of
the transcriptional effects of chromatin
mutants and by the more recent ability
to map chromatin structure genome-
wide. However, disentangling the con-
nection between chromatin state and
gene transcription requires the ability to
specifically perturb histone modification
patterns in a locus-specific manner—in
other words, a way to rationally edit the
‘‘epigenome.’’ In this issue of Cell, Hath-
away et al. (2012) demonstrate a powerful
new technique to artificially induce site-
specific heterochromatin domains in vivo.
In the past decade, so-called epige-
nomic efforts have mapped histone modi-
fications and DNA modifications across
the genomes of organisms from yeast to
humans (Rando and Chang, 2009). In
general, these studies find that ‘‘epige-
netic’’ marks at specific genes exhibit
strong correlations with gene expression
level, leading to the notion that specific
epigenetic marks direct the transcrip-
tional activity of nearby genes. Yet for
histone modifications this connection
isn’t quite so clear. Histone modifications
such as lysine 27 trimethylation on histone
3 (H3K27me3) and H3K9me3 associate
with silent genes, whereas marks such
as H3K4me3, H3K36me3, and H3K27
acetlyation associate with active genes,
yet loss of the enzymes that create these
marks typically has very constrained
effects on a small subset of the genes1422 Cell 149, June 22, 2012 ª2012 Elseviercarrying these marks (Jiang et al., 2011;
Lenstra et al., 2011). Because many his-
tone modifications are deposited during
the process of transcription and may
also affect transcriptional output, dissect-
ing the interplay between histone modifi-
cation and function has been to some
extent waiting on an experimental tech-
nology capable of ‘‘writing’’ a specific pat-
tern of histone marks on a reporter gene.
A second pressing question in the chro-
matin community concerns the herita-
bility of chromatin state—whereas classic
genetic studies on cell-state inheritance in
flies (Ringrose and Paro, 2004) and epige-
netic inheritance of gene silencing in fungi
(Rusche´ et al., 2002) implicate histone
modifying enzymes in epigenetic inheri-
tance paradigms, it is clear that the
majority of histone modification states
across a genome are not epigenetically
heritable (Ptashne, 2007). Even in cases
where gene expression states are epige-
netically heritable, identification of the
carrier of epigenetic information during
genomic replication typically is elusive
(Zacharioudakis et al., 2007). Identifying
cases where the chromatin state per se
is the underlyingmechanism of epigenetic
inheritance is therefore a key challenge in
the field.
Hathaway et al. present a breakthrough
technique in the artificial induction of
epigenetic marks and use this experi-
mental model to test the properties of a
heterochromatic domain induced in a
nonnative location. Technically, Hath-
away et al. bring a major breakthrough
to the field of chromatin biology with the
development of a system that has the
capacity to directly alter local chromatin
structure rapidly in the absence of ex-
ternal signaling. Hathway et al. describeInc.a multicomponent targeting system that
they call the chromatin in vivo assay
(CiA), in which they generate mouse
embryonic stem cells carrying an Oct4-
GFP fusion driven by a modified promoter
carrying several specific TF binding sites
(Figure 1). This technique utilizes two
distinct ‘‘dimerizers’’—small molecules
that bind simultaneously to two distinct
protein domains, thus enabling tight tem-
poral control over protein recruitment
in vivo. By engineering appropriate DNA
binding domains fused to one half of
each dimerizer system, Hathway et al.
are then able to rapidly and reversibly
recruit either the transcriptional activator
VP16 or the heterochromatin protein
HP1 to this CiA:Oct4 reporter in various
cell types and subsequently assay for
gene activity with single-cell resolution.
Using their system, the authors demon-
strate that induction of a local H3K9me3
chromatin domain surrounding CiA:Oct4
is able to rapidly suppress gene activity
in ES cells, despite this reporter residing
in an ‘‘active’’ chromatin domain (Mik-
kelsen et al., 2007) and despite the ES
cells being maintained under conditions
that maintain high levels of transcription
at the endogenous Oct4 gene. After
5 days of csHP1a recruitment, not only
domost cells lose GFP signal, but surpris-
ingly H3K9 methylation spreads over a
10 kb domain surrounding the targeted
promoter. Although repressive histone
marks in constitutive heterochromatic
domains such as subtelomeric regions
are known to spread fromnucleation sites,
the spreading observed at the CiA:Oct4
promoter indicates that this spreading
does not require specific underlying
sequence elements (repetitive gene fami-
lies, etc.).
Figure 1. A System for Editing the Epi-
genome
Schematic diagram of the CiA:Oct4 system
described by Crabtree and colleagues in this issue
of Cell. Hathaway et al. engineered murine ES cells
carrying a modified Oct4 promoter with two new
transcription factor binding sites (red and green),
driving a GFP reporter. Each transcription factor
was fused to half of a ‘‘dimerizer’’ system, allowing
rapid small molecule-mediated recruitment of
either the repressor protein HP1 or the transcrip-
tional activator domain of VP16, as shown. By
recruiting either HP1, VP16, or both to the reporter
gene, Hathaway et al. were able to assess the
effects of artificial induction of a heterochromatin
domain on gene expression in vivo.Are heterochromatin domains stably
maintained in the absence the original
stimulus? Intriguingly, this depends on
the length of time spent in the repressed
state—washing out the HP1-recruiting
stimulus after 7 days of HP1 recruitment
allows most cells to reactivate Oct4-
GFP, whereas 4.5 weeks of HP1 recruit-
ment results in a stably repressed stateeven in the absence of artificial HP1
recruitment. This stably-repressed state,
but not the repressed state after 7 days,
is associated with a local gain in cytosine
methylation. This result is strangely remi-
niscent of X chromosome inactivation,
where early expression of Xist ncRNA
leads to recruitment of Polycomb com-
plexes and eventually to DNA methyla-
tion, which can then maintain the re-
pressed state even after deletion of Xist
(the original stimulus) (Csankovszki et al.,
2001).
BecauseOct4 is normally transcribed in
ES cells, the authors carry out an analo-
gous series of experiments in embryonic
fibroblasts (MEFs) to study the stability
of heterochromatic states in cells where
repression will not be antagonized by
otherOct4 promoter binding transcription
factors. Here, HP1 recruitment results in
persistence of H3K9me3 for at least
8 days in a manner unaffected by the
cytosine methylation inhibitor 5azaC,
demonstrating that this artificial hetero-
chromatin domain can be epigenetically
heritable in the absence of antagonistic
transcription. Conversely, the authors
find that recruiting VP16 to the CiA:Oct4
promoter in MEFs was sufficient to rapidly
overcome the native repressed state of
the Oct4 promoter in these cells, a
surprising result thatmay aid future efforts
to derive induced pluripotent stem cells
that normally require several weeks for
endogenous Oct4 reactivation. An inter-
esting corollary to this finding comes
from recent work in several groups identi-
fying small molecules that aid in iPS cell
generation. Among these small molecules
are inhibitors of G9a, the primary enzyme
responsible for dimethylation of H3K9,
suggesting that although a strong tran-
scriptional activator can reset local chro-
matin structures as described in Hath-
away et al., weak endogenous activators
may be more efficient in the absence of
repressive chromatin marks (Shi et al.,
2008).
This work by Hathaway et al. presents
a substantial leap forward in the creation
of tools to aid our understanding of chro-
matin structure in biology. Furthermore,
their ability to locally rewrite the epige-
nome has produced intriguing findings
suggesting that the balance betweenCell 14gene silencing and repression is surpris-
ingly malleable. On each side of this
balancing act are self-reinforcing feed-
back mechanisms that act to stabilize
the active or the repressive state. On the
active side, gene transcription is associ-
ated with significant chromatin remodel-
ing, with histone replacement resulting in
efficient erasure of repressive histone
marks. On the inactive side, local recruit-
ment of repressive chromatin marks in-
duces spreading of the repressive domain
locally, and eventual recruitment of addi-
tional repressive machinery such as that
involved in DNA methylation. Despite
these stabilizing influences on the active
and repressed states, Hathaway et al.
show that direct manipulation of local
chromatin structure can tip the scales of
gene activity in vivo. Future studies using
this powerful technique will surely im-
prove our understanding of how positive
feedback loops in chromatin can maintain
stable states of gene expression, while at
the same time allowing flexibility for genes
to be rapidly turned on or off.REFERENCES
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